Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization

A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy

(2011) Ida Manna et al.   EPILEPSIA

Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy

(2011) Hongmei Meng et al.   EPILEPSY & BEHAVIOR

Differential role of sodium channelsSCN1AandSCN2Agene polymorphisms with epilepsy and multiple drug resistance in the north Indian population

(2009) Ram Lakhan et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Genetic Variants in Microsomal Epoxide Hydrolase Influence Carbamazepine Dosing

(2009) Mohd Makmor-Bakry et al.   CLINICAL NEUROPHARMACOLOGY

Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies

(2009) Patrick Kwan et al.   EPILEPSIA

Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 −24C>T polymorphism in young and adult patients with epilepsy

(2009) Mike Ufer et al.   Pharmacogenetics and Genomics

Association betweenSCN1Apolymorphism and carbamazepine-resistant epilepsy

(2008) Tomohide Abe et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

A functional polymorphism in theSCN1Agene is not associated with carbamazepine dosages in Austrian patients with epilepsy

(2008)   EPILEPSIA

The clinical impact of pharmacogenetics on the treatment of epilepsy

(2008) Wolfgang Löscher et al.   EPILEPSIA

UDP-Glucuronosyltransferase 2B7 C802T(His268Tyr) Polymorphism in Bladder Cancer Cases

(2008) Anna Zimmermann et al.   JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES

Several major antiepileptic drugs are substrates for human P-glycoprotein

(2008) Carlos Luna-Tortós et al.   NEUROPHARMACOLOGY